CDKN2AIP antibody (AA 301-400)
Quick Overview for CDKN2AIP antibody (AA 301-400) (ABIN706136)
Target
See all CDKN2AIP AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 301-400
-
Purpose
- CDKN2AIP Polyclonal Antibody
-
Predicted Reactivity
- Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CARF
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000),
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- CDKN2AIP (CDKN2A Interacting Protein (CDKN2AIP))
-
Alternative Name
- CDKN2AIP
-
Background
-
Synonyms: Calcium response factor, CARF, CDKN2A interacting protein, CDKN2AIP, ALS2CR8, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein, Calcium-response factor, CaRF, Testis development protein NYD-SP24, AL2S8_HUMAN.
Background: CARF was first cloned as a novel binding partner of ARF from a yeast interactive screen. CARF and ARF colocalize in the perinucleolar region and have a collaborative function. In the nucleoplasm, CARF interacts with p53 and enhances its function. The p53 downregulates CARF in a negative feedback regulatory loop and may also involve p53 antagonist HDM2.
-
Gene ID
- 55602
Target
-